Back to mobile site

Somalogic (SLGC) Guides FY2022 Revenue of $105M-$110M

February 4, 2022 8:00 AM EST
Get Alerts SLGC Hot Sheet
Price: $2.10 --0%

Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE

SomaLogic, Inc., (NASDAQ: SLGC) a leader in AI-data driven proteomics technology, will host a virtual analyst and investor meeting today, February 4th, 2022, from 10:00 a.m. to approximately 1:00 p.m. Eastern Time. The event is intended to highlight recent corporate updates, technical specifications and capabilities of the SomaScan platform, and various applications across life science tools and clinical diagnostics. SomaLogic management will be joined by leading experts and partners to discuss several ongoing initiatives demonstrating the vast potential for proteomics to deliver meaningful insights that can positively impact human health.

2022 Revenue Guidance

In conjunction with the event, SomaLogic is providing full-year 2022 revenue guidance. Management projects 2022 revenue of approximately $105 million to $110 million.

“We are excited about the strong revenue growth we have recognized over the past few years and our outlook for 2022,” said Roy Smythe, M.D., Chief Executive Officer of SomaLogic. “We are growing the size of our commercial team substantially and diversifying our unique offerings for our customers and collaborators. These successful efforts, along with the rapidly increasing demand for proteomics solutions and services means the future is incredibly bright for SomaLogic.”

Note, in early January SomaLogic announced expectations for 2021 revenues to exceed $79 million, the high-end of prior guidance. SomaLogic will announce final fourth quarter and full-year 2021 results during its earnings call in March.

Analyst and Investor Meeting

A live and archived webcast of the analyst and investor meeting is available on the “Investors” section of the company’s website at https://investors.somalogic.com.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Guidance

Related Entities

Twitter, Earnings, FDA